Dynacord Stem Cell Research

DYNACORD partners with local Medical Research Institutions to perform cutting edge research on the regenerative properties of stem cell derived exosomes and their contents. Together with our researchers, we are laying the foundation for developing FDA-approved clinical exosome products. Exosomes are the functional mechanism of the regenerative process provided by MSC Stem Cells. Due to the fact that Dynacord Exosomes are a cell-free product, they avoid the common risks associated with live cell biologics. Unfortunately, abuses in the regenerative medicine industry have caused swaths of misinformation. The FDA has recently notified the industry that all regenerative medicine products intended for clinical use must go through their regulatory process. Dynacord has worked tirelessly to abide by all FDA regulations and has recently registered a Biologic Drug Masterfile with the FDA for its MSC Exosomes. Exosomes are small vesicles that are secreted by stem cells. They contain large amounts of growth factors, cytokines and other substances with high regenerative potential that can be transferred to other cells due to their unique structure. This structure allows the exosomes to fuse with other cells in the body and to release their content into other cells. The contents of the exosomes such as cytokines, growth factors and mRNA can then help the cell heal itself due to the actions of the transferred signaling molecules. Contrary to stem cells, exosomes do not replicate, do not contain DNA and do not elicit an immune response, resulting in a safer product compared to stem cells. By definition, exosome products are cell free and do not contain any live cells.